Selected research
Market Structure
Global Lipid Contract Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Lipid Contract Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Lipid Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Lipid Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lipid Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Lipid Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lipid Contract Manufacturing include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid and Polymun Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Lipid Contract Manufacturing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Lipid Contract Manufacturing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Lipid Contract Manufacturing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lipid Contract Manufacturing market size, projected growth trends, production technologies, key applications, and end-use industries.
Lipid Contract Manufacturing Segment by Company
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
Lipid Contract Manufacturing Segment by Type
Liposomes
Lipid Nanoparticles
Lipid Contract Manufacturing Segment by Application
Preclinical
Clinical
Commercial
Lipid Contract Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lipid Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Contract Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lipid Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lipid Contract Manufacturing industry.
Chapter 3: Detailed analysis of Lipid Contract Manufacturing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Contract Manufacturingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liposomes
- Lipid Nanoparticles
Applications
- Preclinical
- Clinical
- Commercial
Companies covered
- Precision NanoSystems
- Evonik
- Merck KGaA
- Genevant Sciences
- Exelead
- Avanti Polar Lipids
- Nippon Fine Chemical
- Lipoid
- Polymun Scientific
- Corden Pharma
- Acuitas Therapeutics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Lipid Contract Manufacturing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Liposomes
- 1.2.3 Lipid Nanoparticles
- 1.3 Market Analysis by Application
- 1.3.1 Global Lipid Contract Manufacturing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Preclinical
- 1.3.3 Clinical
- 1.3.4 Commercial
- 1.4 Global Market Growth Prospects
- 1.5 Global Lipid Contract Manufacturing Growth Trends by Region
- 1.5.1 Global Lipid Contract Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Lipid Contract Manufacturing Market Size by Region (2021-2026)
- 1.5.3 Lipid Contract Manufacturing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Lipid Contract Manufacturing Market Dynamics
- 2.1 Lipid Contract Manufacturing Industry Trends
- 2.2 Lipid Contract Manufacturing Industry Drivers
- 2.3 Lipid Contract Manufacturing Industry Opportunities and Challenges
- 2.4 Lipid Contract Manufacturing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Lipid Contract Manufacturing Revenue by Company (2021-2026)
- 3.2 Global Lipid Contract Manufacturing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Lipid Contract Manufacturing Key Company Head office and Area Served
- 3.4 Global Lipid Contract Manufacturing Company, Product Type & Application
- 3.5 Global Lipid Contract Manufacturing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Lipid Contract Manufacturing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Lipid Contract Manufacturing Players Market Share by Revenue in 2025
- 3.6.3 2025 Lipid Contract Manufacturing Tier 1, Tier 2, and Tier 3
4 Lipid Contract Manufacturing Market by Type
- 4.1 Global Lipid Contract Manufacturing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Lipid Contract Manufacturing Market Size by Type (2021-2032)
- 4.3 Global Lipid Contract Manufacturing Market Size Share by Type (2021-2032)
5 Lipid Contract Manufacturing Market by Application
- 5.1 Global Lipid Contract Manufacturing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Lipid Contract Manufacturing Market Size by Application (2021-2032)
- 5.3 Global Lipid Contract Manufacturing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Precision NanoSystems
- 6.1.1 Precision NanoSystems Company Information
- 6.1.2 Precision NanoSystems Business Overview
- 6.1.3 Precision NanoSystems Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Precision NanoSystems Lipid Contract Manufacturing Product Portfolio
- 6.1.5 Precision NanoSystems Recent Developments
- 6.2 Evonik
- 6.2.1 Evonik Company Information
- 6.2.2 Evonik Business Overview
- 6.2.3 Evonik Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Evonik Lipid Contract Manufacturing Product Portfolio
- 6.2.5 Evonik Recent Developments
- 6.3 Merck KGaA
- 6.3.1 Merck KGaA Company Information
- 6.3.2 Merck KGaA Business Overview
- 6.3.3 Merck KGaA Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Merck KGaA Lipid Contract Manufacturing Product Portfolio
- 6.3.5 Merck KGaA Recent Developments
- 6.4 Genevant Sciences
- 6.4.1 Genevant Sciences Company Information
- 6.4.2 Genevant Sciences Business Overview
- 6.4.3 Genevant Sciences Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Genevant Sciences Lipid Contract Manufacturing Product Portfolio
- 6.4.5 Genevant Sciences Recent Developments
- 6.5 Exelead
- 6.5.1 Exelead Company Information
- 6.5.2 Exelead Business Overview
- 6.5.3 Exelead Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Exelead Lipid Contract Manufacturing Product Portfolio
- 6.5.5 Exelead Recent Developments
- 6.6 Avanti Polar Lipids
- 6.6.1 Avanti Polar Lipids Company Information
- 6.6.2 Avanti Polar Lipids Business Overview
- 6.6.3 Avanti Polar Lipids Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Avanti Polar Lipids Lipid Contract Manufacturing Product Portfolio
- 6.6.5 Avanti Polar Lipids Recent Developments
- 6.7 Nippon Fine Chemical
- 6.7.1 Nippon Fine Chemical Company Information
- 6.7.2 Nippon Fine Chemical Business Overview
- 6.7.3 Nippon Fine Chemical Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Nippon Fine Chemical Lipid Contract Manufacturing Product Portfolio
- 6.7.5 Nippon Fine Chemical Recent Developments
- 6.8 Lipoid
- 6.8.1 Lipoid Company Information
- 6.8.2 Lipoid Business Overview
- 6.8.3 Lipoid Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lipoid Lipid Contract Manufacturing Product Portfolio
- 6.8.5 Lipoid Recent Developments
- 6.9 Polymun Scientific
- 6.9.1 Polymun Scientific Company Information
- 6.9.2 Polymun Scientific Business Overview
- 6.9.3 Polymun Scientific Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Polymun Scientific Lipid Contract Manufacturing Product Portfolio
- 6.9.5 Polymun Scientific Recent Developments
- 6.10 Corden Pharma
- 6.10.1 Corden Pharma Company Information
- 6.10.2 Corden Pharma Business Overview
- 6.10.3 Corden Pharma Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Corden Pharma Lipid Contract Manufacturing Product Portfolio
- 6.10.5 Corden Pharma Recent Developments
- 6.11 Acuitas Therapeutics
- 6.11.1 Acuitas Therapeutics Company Information
- 6.11.2 Acuitas Therapeutics Business Overview
- 6.11.3 Acuitas Therapeutics Lipid Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Acuitas Therapeutics Lipid Contract Manufacturing Product Portfolio
- 6.11.5 Acuitas Therapeutics Recent Developments
7 North America
- 7.1 North America Lipid Contract Manufacturing Market Size (2021-2032)
- 7.2 North America Lipid Contract Manufacturing Market Size by Type
- 7.2.1 North America Lipid Contract Manufacturing Market Size by Type (2021-2026)
- 7.2.2 North America Lipid Contract Manufacturing Market Size by Type (2027-2032)
- 7.2.3 North America Lipid Contract Manufacturing Market Share by Type (2021-2032)
- 7.3 North America Lipid Contract Manufacturing Market Size by Application
- 7.3.1 North America Lipid Contract Manufacturing Market Size by Application (2021-2026)
- 7.3.2 North America Lipid Contract Manufacturing Market Size by Application (2027-2032)
- 7.3.3 North America Lipid Contract Manufacturing Market Share by Application (2021-2032)
- 7.4 North America Lipid Contract Manufacturing Market Size by Country
- 7.4.1 North America Lipid Contract Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Lipid Contract Manufacturing Market Size by Country (2021-2026)
- 7.4.3 North America Lipid Contract Manufacturing Market Size by Country (2027-2032)
- 7.4.4 North America Lipid Contract Manufacturing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Lipid Contract Manufacturing Market Size (2021-2032)
- 8.2 Europe Lipid Contract Manufacturing Market Size by Type
- 8.2.1 Europe Lipid Contract Manufacturing Market Size by Type (2021-2026)
- 8.2.2 Europe Lipid Contract Manufacturing Market Size by Type (2027-2032)
- 8.2.3 Europe Lipid Contract Manufacturing Market Share by Type (2021-2032)
- 8.3 Europe Lipid Contract Manufacturing Market Size by Application
- 8.3.1 Europe Lipid Contract Manufacturing Market Size by Application (2021-2026)
- 8.3.2 Europe Lipid Contract Manufacturing Market Size by Application (2027-2032)
- 8.3.3 Europe Lipid Contract Manufacturing Market Share by Application (2021-2032)
- 8.4 Europe Lipid Contract Manufacturing Market Size by Country
- 8.4.1 Europe Lipid Contract Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Lipid Contract Manufacturing Market Size by Country (2021-2026)
- 8.4.3 Europe Lipid Contract Manufacturing Market Size by Country (2027-2032)
- 8.4.4 Europe Lipid Contract Manufacturing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Lipid Contract Manufacturing Market Size (2021-2032)
- 9.2 China Lipid Contract Manufacturing Market Size by Type
- 9.2.1 China Lipid Contract Manufacturing Market Size by Type (2021-2026)
- 9.2.2 China Lipid Contract Manufacturing Market Size by Type (2027-2032)
- 9.2.3 China Lipid Contract Manufacturing Market Share by Type (2021-2032)
- 9.3 China Lipid Contract Manufacturing Market Size by Application
- 9.3.1 China Lipid Contract Manufacturing Market Size by Application (2021-2026)
- 9.3.2 China Lipid Contract Manufacturing Market Size by Application (2027-2032)
- 9.3.3 China Lipid Contract Manufacturing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Lipid Contract Manufacturing Market Size (2021-2032)
- 10.2 Asia Lipid Contract Manufacturing Market Size by Type
- 10.2.1 Asia Lipid Contract Manufacturing Market Size by Type (2021-2026)
- 10.2.2 Asia Lipid Contract Manufacturing Market Size by Type (2027-2032)
- 10.2.3 Asia Lipid Contract Manufacturing Market Share by Type (2021-2032)
- 10.3 Asia Lipid Contract Manufacturing Market Size by Application
- 10.3.1 Asia Lipid Contract Manufacturing Market Size by Application (2021-2026)
- 10.3.2 Asia Lipid Contract Manufacturing Market Size by Application (2027-2032)
- 10.3.3 Asia Lipid Contract Manufacturing Market Share by Application (2021-2032)
- 10.4 Asia Lipid Contract Manufacturing Market Size by Country
- 10.4.1 Asia Lipid Contract Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Lipid Contract Manufacturing Market Size by Country (2021-2026)
- 10.4.3 Asia Lipid Contract Manufacturing Market Size by Country (2027-2032)
- 10.4.4 Asia Lipid Contract Manufacturing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Lipid Contract Manufacturing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Type
- 11.2.1 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Lipid Contract Manufacturing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Application
- 11.3.1 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Lipid Contract Manufacturing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Country
- 11.4.1 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Lipid Contract Manufacturing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst